Evolent Health (EVH) Q2 2023 Earnings Call Transcript
The Motley Fool
AUGUST 2, 2023
While acquisitions contributed a portion of the year-over-year growth in adjusted EBITDA, we're also benefiting from a healthy mix of higher pull-through of specialty technology and services, as well as maturation of the performance we book. And as we go around and talk to customers and prospects, that's certainly what the market wants.
100 
Let's personalize your content